Global Recombinant Proteins Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Recombinant Proteins Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Recombinant Proteins market size was valued at USD 1004 million in 2022 and is forecast to a readjusted size of USD 2284.2 million by 2029 with a CAGR of 12.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.

This report is a detailed and comprehensive analysis for global Recombinant Proteins market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Recombinant Proteins market size and forecasts, in consumption value ($ Million), 2018-2029

Global Recombinant Proteins market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Recombinant Proteins market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Recombinant Proteins market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Recombinant Proteins

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Recombinant Proteins market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec and Thermo Fisher Scientific, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Recombinant Proteins market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

Market segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations

Market segment by players, this report covers
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Recombinant Proteins product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Recombinant Proteins, with revenue, gross margin and global market share of Recombinant Proteins from 2018 to 2023.

Chapter 3, the Recombinant Proteins competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Recombinant Proteins market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Proteins.

Chapter 13, to describe Recombinant Proteins research findings and conclusion.